News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC
Joe Y. Chang/X
Mar 30, 2025, 16:56

Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC

Joe Chang, Director of the Stereotactic Ablative Radiotherapy Program at MD Anderson Cancer Center, shared a post on X:

“Optimal first-line treatment for EGFR-mutated mNSCLC?

  1. Tagrisso alone for most patients.
  2. Tagrisso plus chemo for high-risk patients (brain/liver mets or large size)
  3. Amivantamab: Ab EGFR and MET. Lazertinib: EGFR TK

Don’t forget: SABR plus Tagrisso for oligomets or oligoprogression.”

Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC

More posts featuring Joe Chang.

cancer EGFR Joe Chang mNSCLC OncoDaily Oncology
Special Coverage
Blog
Apr 22, 2025, 07:01
Alejandra Mendez: Still feeling inspired after an unforgettable 17th CCI Asia Conference - SIOP Asia 2025
Blog
Apr 22, 2025, 06:53
Triparna Sen: I am truly thrilled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 22, 2025, 06:40
Elvina Almuradova: Trodelvy plus Keytruda Boosts PFS in PD-L1+ mTNBC Patients
Blog
Apr 22, 2025, 06:34
Join Florez Lab's Lung Cancer Team as they walk for hope, healing, and a future without lung cancer
Science
Apr 22, 2025, 06:32
John Oluwafemi Teibo: Excited to share our latest publication on the molecular effectors of the CAR-T Cell therapy in Cancer Management
Blog
Apr 22, 2025, 06:26
ESGO - Juan Carlos Torrejon Becerra completed the ESGO training program
Blog
Apr 22, 2025, 06:18
Fight Colorectal Cancer - 38 healthcare organizations urge Supreme Court to protect Free Cancer Screenings
Blog
Apr 22, 2025, 06:11
Los Angeles volunteer Chuck O’Shea credits City of Hope with saving his life
Blog
Apr 22, 2025, 06:03
The Jimmy Fund - Dana-Farber Marathon Challenge team runners take on the 129th Boston Marathon!
Blog
Apr 22, 2025, 05:57
ASCO - Optimizing Oncology Clinical Pathways at the Point of Care
Blog
Apr 22, 2025, 05:43
Newly elected Fellows of the AACR Academy will be recognized during the AACR25 Opening Ceremony
Blog
Apr 22, 2025, 05:37
Dana-Farber Cancer Institute - Benjamin L. Ebert was recognized with the Erasmus Hematology Award